Predict your next investment

Pregnolia company logo
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment

See what CB Insights has to offer

Founded Year



Corporate Minority | Alive

Total Raised


About Pregnolia

Pregnolia is a medical device company in the stage of clinical development. It focuses on the development and commercialization of a diagnostic device to identify women at risk for preterm delivery early in pregnancy such that gynecologists can make key decisions about preterm birth management. It aims to reduce the number of premature babies worldwide.

Pregnolia Headquarter Location

Wiesenstrasse 33

Zurich, 8952,


+41 44 500 84 35

Latest Pregnolia News

Sanitas invests in Pregnolia

May 11, 2021

News Schlieren ZH – The health insurance provider Sanitas is supporting a device from the MedTech start-up Pregnolia that is used to detect premature births. It is taking on the costs of the check-up and investing in the company. Pregnolia  has developed an instrument to detect the risks of premature birth. To do so, a probe measures the stiffness of the cervix. If it is too soft, the physician can initiate therapeutic measures in good time. One of the start-up’s aims is to identify asymptomatic women who could benefit from intervention in the early stages of pregnancy. Sanitas  is the first health insurance provider in Switzerland to take on the costs of a check-up using the Pregnolia device according to a press release . This is covered within outpatient supplementary insurance. Sanitas is also investing in Pregnolia. According to an article on, there are plans for a “modest” investment. Pregnolia was already able to secure 4 million Swiss francs in a funding round last summer. Sabrina Badir, CEO and Founder of Pregnolia, is quoted as saying: ““We’re delighted that Sanitas is supporting our startup as we ready the product for broad market release and that, by reimbursing check-ups done using our technology, it is sending out a strong signal for innovation in the market.” Badir founded Pregnolia as a spin-off from the Swiss Federal Institute of Technology in Zurich ( ETH ). The start-up is headquartered in Schlieren. Related news

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pregnolia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pregnolia is included in 3 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,447 items

Startups focused on providing products and services catering to women's health and wellbeing.


Medical Devices

7,891 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.